Brief: Zero Candida Announces Plans To Complete Preclinical Studies For FDA Submission By Q3 2025
06/01/2025 14:46
Zero Candida Technologies Inc ZCT.V :
* ZERO CANDIDA ANNOUNCES PLANS TO COMPLETE PRECLINICAL
STUDIES FOR
FDA SUBMISSION BY Q3 2025
Source text: ID:nPred8RMBa
Further company coverage: ZCT.V
Recent news on Zero Candida Technologies
See all newsBrief: Zero Candida Technologies Reports Financial Results For Three And Six Months Ended June 30, 2025 And Provides Business Update
Brief: Zero Candida Technologies Reports Financial Results For Three And Six Months Ended June 30, 2025 And Provides Business Update
Brief: Zero Candida Technologies Announces Successful Listing On Frankfurt Stock Exchange
Brief: Zero Candida Announces Plans To Complete Preclinical Studies For FDA Submission By Q3 2025
Brief: Zero Candida Receives South African Patent For Its Zc- 01 Device